Frontlight ResearchEarly access
WithdrawnNo phase
PPI Versus Placebo in Severe Functional Heartburn
Key facts
- Who runs it
- University of Southern California
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- Oct 2003
- Expected to end
- 1 Dec 2100
- Type of study
- Interventional
- Treatments tested
- PPI
- Record updated
- 14 April 2017
- Why it stopped
- Study never started.
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Heartburn twice a week for at least 2 years. Normal EGD and 24hr pH study
Who cannot take part
- <18yrs of age,pregnant, unable or unwilling to give consent, allergic to PPI, previous gastric or esophageal surgery, past hx of erosive GERD, unwilling or unable to stop acid suppression meds
Where in United States
- USC Keck School of MedicineLos Angeles, United States
About the trial
What the trial wants to find out
Proton Pump Inhibitors are no better than placebo in relieving GERD symptoms in patients with functional Heartburn.
The group in the trial
- no label studyOther group
1
Treatment: PPI
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 14 April 2017